Clinical Trial Update: In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated potential interactions between Tenofovir 1% vaginal gel and three commonly used vaginal products in HIV prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir 1% vaginal gel (tenofovir)

Snippet

Sponsor: CONRAD | Conditions: HIV Prevention | Phase 1 | Status: COMPLETED